| Literature DB >> 32008135 |
Ana Van Den Rym1,2,3, Prasad Taur4, Rubén Martinez-Barricarte5, Lazaro Lorenzo6, Anne Puel5,6,7, Pablo Gonzalez-Navarro1,2,3, Ambreen Pandrowala4, Vijaya Gowri4, Amin Safa1,2,3,8, Victor Toledano2, Carolina Cubillos-Zapata2,9, Eduardo López-Collazo2, Maria Vela10, Antonio Pérez-Martínez10,11, Silvia Sánchez-Ramón3,12, Maria J Recio3,8, Jean-Laurent Casanova5,6,7,13,14, Mukesh M Desai4, Rebeca Perez de Diego15,16,17.
Abstract
In 2014, a child with broad combined immunodeficiency (CID) who was homozygous for a private BCL10 allele was reported to have complete inherited human BCL10 deficiency. In the present study, we report a new BCL10 mutation in another child with CID who was homozygous for a BCL10 variant (R88X), previously reported as a rare allele in heterozygosis (minor allele frequency, 0.000003986). The mutant allele was a loss-of-expression and loss-of-function allele. As with the previously reported patient, this patient had complete BCL10 deficiency. The clinical phenotype shared features, such as respiratory infections, but differed from that of the previous patient that he did not develop significant gastroenteritis episodes or chronic colitis. Cellular and immunological phenotypes were similar to those of the previous patient. TLR4, TLR2/6, and Dectin-1 responses were found to depend on BCL10 in fibroblasts, and final maturation of T cell and B cell maturation into memory cells was affected. Autosomal-recessive BCL10 deficiency should therefore be considered in children with CID.Entities:
Keywords: Autosomal recessive; BCL10; Beta-glucan receptor Dectin-1; Combined immunodeficiency; Fibroblast; Lymphoid cells; Primary immunodeficiency; Receptor; Toll-like receptors
Mesh:
Substances:
Year: 2020 PMID: 32008135 DOI: 10.1007/s10875-020-00760-3
Source DB: PubMed Journal: J Clin Immunol ISSN: 0271-9142 Impact factor: 8.317